IL79549A0 - (4-substituted-piperazinyl)pyridazines,their preparation and pharmaceutical compositions containing them - Google Patents

(4-substituted-piperazinyl)pyridazines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL79549A0
IL79549A0 IL79549A IL7954986A IL79549A0 IL 79549 A0 IL79549 A0 IL 79549A0 IL 79549 A IL79549 A IL 79549A IL 7954986 A IL7954986 A IL 7954986A IL 79549 A0 IL79549 A0 IL 79549A0
Authority
IL
Israel
Prior art keywords
pyridazines
piperazinyl
substituted
preparation
pharmaceutical compositions
Prior art date
Application number
IL79549A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL79549A0 publication Critical patent/IL79549A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL79549A 1985-07-31 1986-07-29 (4-substituted-piperazinyl)pyridazines,their preparation and pharmaceutical compositions containing them IL79549A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76084585A 1985-07-31 1985-07-31

Publications (1)

Publication Number Publication Date
IL79549A0 true IL79549A0 (en) 1986-10-31

Family

ID=25060338

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79549A IL79549A0 (en) 1985-07-31 1986-07-29 (4-substituted-piperazinyl)pyridazines,their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
EP (1) EP0211457A3 (fr)
JP (1) JPS6229575A (fr)
KR (1) KR870001192A (fr)
CN (1) CN86105558A (fr)
AU (1) AU6073986A (fr)
DK (1) DK363186A (fr)
ES (1) ES8802151A1 (fr)
FI (1) FI863120A (fr)
GR (1) GR862022B (fr)
HU (1) HU195501B (fr)
IL (1) IL79549A0 (fr)
NO (1) NO863083L (fr)
NZ (1) NZ216918A (fr)
PH (1) PH22884A (fr)
PT (1) PT83098B (fr)
TN (1) TNSN86117A1 (fr)
ZA (1) ZA865700B (fr)
ZW (1) ZW14886A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104343A (en) * 1987-11-23 1994-03-31 Janssen Pharmaceutica Nv Novel pyridizinamine deravatives
US4992433A (en) * 1987-11-23 1991-02-12 Janssen Pharmaceutica N.V. Novel pyridazinamine derivatives
US5070090A (en) * 1989-05-15 1991-12-03 Janssen Pharmaceutica N.V. Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines
US5270312A (en) * 1990-11-05 1993-12-14 Warner-Lambert Company Substituted piperazines as central nervous system agents
SK285198B6 (sk) * 1997-10-27 2006-08-03 Neurosearch A/S Homopiperazínový derivát, farmaceutická kompozícia obsahujúca tento derivát a jeho použitie
JP2002543070A (ja) 1999-04-26 2002-12-17 ニューロサーチ、アクティーゼルスカブ ヘテロアリールジアザシクロアルカン類、その製造方法及びその使用方法
US20030176437A1 (en) 2001-08-31 2003-09-18 D.M. Watterson Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
US7390813B1 (en) 2001-12-21 2008-06-24 Xenon Pharmaceuticals Inc. Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
US7754711B2 (en) 2003-07-30 2010-07-13 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
SG145699A1 (en) 2003-07-30 2008-09-29 Xenon Pharmaceuticals Inc Pyridazine derivatives and their use as therapeutic agents
US7759348B2 (en) 2003-07-30 2010-07-20 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
EP3042895A1 (fr) 2003-07-30 2016-07-13 Xenon Pharmaceuticals Inc. Dérivés de la pipérazine et leur utilisation en tant qu'agents thérapeutiques
TW200626154A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
MX2007003327A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa.
JP5149009B2 (ja) 2004-09-20 2013-02-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド ヒトステアロイル−CoAデサチュラーゼを阻害するためのピリダジン誘導体
JP5043668B2 (ja) 2004-09-20 2012-10-10 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環誘導体および治療薬としてのそれらの使用
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
BRPI0515483A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase
EP1804799B1 (fr) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Dérivés hétérocycliques et leur utilisation en tant qu'agents thérapeutiques
CA2589102C (fr) 2004-11-02 2013-08-13 Northwestern University Composes de pyridazine et methodes d'utilisation des composes pour traiter les maladies inflammatoires
WO2006050389A2 (fr) 2004-11-02 2006-05-11 Northwestern University Composes pyridazine, compositions et procedes associes
AU2016203312B2 (en) * 2004-11-02 2018-05-24 Centre National De La Recherche Scientifique Pyridazine compounds, compositions and methods
MX2007015216A (es) 2005-06-03 2008-02-22 Xenon Pharmaceuticals Inc Derivados de aminotiazol y sus usos como agentes terapeuticos.
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
CA2650711A1 (fr) 2006-04-28 2007-11-08 Northwestern University Compositions et traitements utilisant des pyridazines et des inhibiteurs de cholinesterase
EP2063894B1 (fr) 2006-04-28 2019-08-28 Northwestern University Formulations contenant des composés de pyridazine pour le traitement de maladies neuro-inflammatoires
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Dopamine 2 receptor antagonists are rapidly hydrolyzed
AU2008240729B2 (en) 2007-04-23 2012-08-23 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
DK2148873T3 (da) 2007-04-23 2012-11-26 Janssen Pharmaceutica Nv 4-alkoxypyridazinderivater som hurtigt dissocierende dopamin 2- receptorantagonister
CA2687931C (fr) * 2007-05-31 2016-05-24 Boehringer Ingelheim International Gmbh Antagonistes des recepteurs ccr2 et utilisations de ceux-ci
ES2622161T3 (es) 2008-07-31 2017-07-05 Janssen Pharmaceutica, N.V. Piridinas sustituidas con piperazin-1-il-trifluorometilo como antagonistas del receptor de la dopamina 2 de disociación rápida
WO2012159662A1 (fr) * 2011-05-24 2012-11-29 Universita' Degli Studi Di Bari Nouveaux ligands 1-arylpipéraziniques de récepteur 5-ht7 et utilisation de ceux-ci
CN108026087B (zh) 2015-07-02 2021-06-04 中枢疗法公司 氨基嘧啶甲酮衍生物的柠檬酸盐

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines

Also Published As

Publication number Publication date
PT83098A (en) 1986-08-01
NZ216918A (en) 1988-11-29
ZA865700B (en) 1988-03-30
NO863083L (no) 1987-02-02
DK363186A (da) 1987-02-01
ZW14886A1 (en) 1988-02-24
HUT41772A (en) 1987-05-28
EP0211457A3 (fr) 1987-07-22
PT83098B (en) 1988-07-13
DK363186D0 (da) 1986-07-30
EP0211457A2 (fr) 1987-02-25
ES556738A0 (es) 1988-04-01
FI863120A0 (fi) 1986-07-30
FI863120A (fi) 1987-02-01
ES8802151A1 (es) 1988-04-01
KR870001192A (ko) 1987-03-12
HU195501B (en) 1988-05-30
TNSN86117A1 (fr) 1990-01-01
GR862022B (en) 1986-12-24
JPS6229575A (ja) 1987-02-07
CN86105558A (zh) 1987-01-28
NO863083D0 (no) 1986-07-30
PH22884A (en) 1989-01-19
AU6073986A (en) 1987-02-05

Similar Documents

Publication Publication Date Title
IL79549A0 (en) (4-substituted-piperazinyl)pyridazines,their preparation and pharmaceutical compositions containing them
IL79323A (en) Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
IL78079A0 (en) Sulphonylaminoethyl compounds,their preparation and pharmaceutical compositions containing them
IL79266A (en) Aralkylpiperidinylbenzyl alcohols,their preparation and pharmaceutical compositions containing them
IL80296A (en) Phenylpyridone derivatives,their preparation and pharmaceutical compositions containing them
IL79309A (en) (heterocyclic substituted-phenoxy)alkyl-isoxazoles and-furans,their preparation and pharmaceutical compositions containing them
IL81322A0 (en) Thieno-1,4-diazepines,their preparation and pharmaceutical compositions containing them
IL78804A (en) N-benzhydrylpiperazinealkananilides,their preparation and pharmaceutical antianaphylactic and antibronchospastic compositions containing them
IL80032A (en) Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
IL84302A0 (en) Substituted alpha-aminoacids,their preparation and pharmaceutical compositions containing them
IL84060A0 (en) Imidazobenzoxazinones,their preparation and pharmaceutical compositions containing them
IL79402A0 (en) Poly-4-aminopyrrole-2-carboxamido derivatives,their preparation and pharmaceutical compositions containing them
IL79039A0 (en) 4-oxoquinolinesulfonamides,their preparation and pharmaceutical compositions containing them
GB2179945B (en) New saccharides, their preparation and pharmaceutical compositions containing them
IL75966A (en) 3-substituted-1-aminoalkyl-1h-indoles,their preparation and pharmaceutical compositions containing them
DE3573784D1 (en) Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
IL79234A0 (en) Pyridazodiazepine phosphates,their preparation and pharmaceutical compositions containing them
IL84633A0 (en) 1-aryloxy-3-amino-2-propanols,their preparation and pharmaceutical compositions containing them
IL85824A (en) Pyrrolealdehydes,their preparation and pharmaceutical compositions containing them
IL78687A0 (en) Acylaminomethyl-penem compounds,their preparation and pharmaceutical compositions containing them
IL78963A0 (en) N-phenyl-1-piperazine carboxamidines and related compounds,their preparation and pharmaceutical compositions containing them
IL77614A (en) Interfuranylene-prostacyclin derivatives,their preparation and pharmaceutical compositions containing them
IL80379A0 (en) Gonadoliberine analogues,their preparation and pharmaceutical compositions containing them
IL81671A0 (en) Substituted pyrimidoindoles,their preparation and pharmaceutical compositions containing them
ZA864799B (en) Saccharides,their preparation and pharmaceutical compositions containing them